Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications

Enterovirus 71 vaccine: close but still far

(2010) Dingmei Zhang et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield

(2010) Cheng-Yu Chung et al.   VACCINE

EV71: An emerging infectious disease vaccine target in the Far East?

(2010) Juan Xu et al.   VACCINE

Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008

(2010) Zhen Zhu et al.   Virology Journal

A comparison of the biological characteristics of EV71 C4 subtypes from different epidemic strains

(2010) Li-chun Wang et al.   VIROLOGICA SINICA

Seroprevalence and molecular epidemiology of enterovirus 71 in Germany

(2009) Sabine Diedrich et al.   ARCHIVES OF VIROLOGY

An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China

(2009) Yong Zhang et al.   JOURNAL OF CLINICAL VIROLOGY

Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71

(2009) Mei-Liang Huang et al.   JOURNAL OF VIROLOGICAL METHODS

Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease

(2009) K. C. Ong et al.   JOURNAL OF VIROLOGY

Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany

(2009) Holger F. Rabenau et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

HLA-A33 Is Associated With Susceptibility to Enterovirus 71 Infection

(2008) L.-Y. Chang et al.   PEDIATRICS

Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection

(2008) Hsiao-Ling Chen et al.   VACCINE